9-130500975-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_054012.4(ASS1):c.1194-1G>C variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,613,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_054012.4 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASS1 | NM_054012.4 | c.1194-1G>C | splice_acceptor_variant | ENST00000352480.10 | NP_446464.1 | |||
ASS1 | NM_000050.4 | c.1194-1G>C | splice_acceptor_variant | NP_000041.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASS1 | ENST00000352480.10 | c.1194-1G>C | splice_acceptor_variant | 1 | NM_054012.4 | ENSP00000253004 | P1 | |||
ASS1 | ENST00000372393.7 | c.1194-1G>C | splice_acceptor_variant | 5 | ENSP00000361469 | P1 | ||||
ASS1 | ENST00000372394.5 | c.1194-1G>C | splice_acceptor_variant | 2 | ENSP00000361471 | P1 | ||||
ASS1 | ENST00000372386.6 | n.465-1G>C | splice_acceptor_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 251074Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135762
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1461450Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 727046
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74304
ClinVar
Submissions by phenotype
Citrullinemia type I Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 16, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 15, 2004 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Counsyl | Aug 16, 2017 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 19, 2017 | Variant summary: The ASS1 c.1194-1G>C variant involves the alteration of a conserved intronic nucleotide located at a position known to affect splicing, which 5/5 splice prediction tools predict a significant impact on normal splicing and ESE finder predicts alterations to ESE binding. A functional study, Su_1990, indicates the variant to affect splicing and cause an elongation of the protein. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 2/121348 (1/60674), which does not exceed the estimated maximal expected allele frequency for a pathogenic ASS1 variant of 1/244. Multiple publications have cited the variant in affected individuals as homozygotes and compound heterozygotes, along with multiple clinical diagnostic laboratories classifying the variant as "likely pathogenic/pathogenic." Therefore, the variant of interest has been classified as "Pathogenic." - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 24, 2024 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 22, 2024 | This variant destroys the canonical splice acceptor site in intron 15, and results in abnormal gene splicing (PMID: 2246255); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24889030, 2246255, 19006241, 24508627, 15266621, 2358466, 15334737, 36939041, 28111830) - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 01, 2014 | - - |
Citrullinemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change affects an acceptor splice site in intron 15 of the ASS1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely disrupts the C-terminus of the protein. This variant is present in population databases (rs727503814, gnomAD 0.003%). Disruption of this splice site has been observed in individual(s) with citrullinemia (PMID: 2246255, 2358466, 15266621, 15334737, 24889030). ClinVar contains an entry for this variant (Variation ID: 166704). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that disruption of this splice site results in 7 bp deletion of exon 16 and introduces a new termination codon (PMID: 17576681). However the mRNA is not expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at